Method for treating von willebrand's disease

Details Method for treating von willebrand's disease Method for treating von willebrand's disease

2005-12-27

2005-12-27

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Transferases

C514S008100, C514S021800

Reexamination Certificate

active

06979445

ABSTRACT:
Use of factor XIII for treating von Willebrand's disease. A patient having von Willebrand's disease is treated by administering factor XIII generally in conjunction with factor VIII concentrate, 1-desamino-8-D-arginine vasopressin (DDAVP) or desmopressin.

REFERENCES:
patent: WO 01/85198 (2001-11-01), None
Nilsson et al. Characteristics Of The Factor-VIII Protein And Factor-XIII In Various Factor-VIII Concentrates. Scandinavian Journal Of Haemotology. 1980, vol. 24, No. 4, pp. 340-349.
Moro et al. Statistic Considerations In The Treatment . . . Rivista Italiana Di Stomatologia. Jul.-Aug. 1983, vol. 72, Nos. 7-8, pp. 589-592.
Beersmh et al. Merck Manual of Diagnosis And Therapy, 17th ed. 1999, pp. 888-889.
Berry. Use Of DDAVP And Cryoprecipitate In Mild To Moderate Haemophilia A And Von Willebrands Disease. Progress In Clinical And Biological Research. 1990, vol. 324, pp. 269-278.

Affiliated with

Also associated with

Rating

Method for treating von willebrand's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating von willebrand's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating von willebrand's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3504686